Home > Insider Trading > Filing (0001209191-14-009833)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1105533	Argos Therapeutics Inc	ARGS	Pharmaceutical Preparations (2834)	562110007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1598754	Public Joint Stock Co Pharmstandard	Likhachevsky Drive 5 &Quot;B&Quot; Dolgoprudny 1Z 1417000		No	No	Yes	No
1598762	S.a. International Pharmstandard	65, Boulevard Grande Duchesse Charlotte Luxembourg N4 L-1331		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-12	4,708,549	$0.00	4,708,549	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2014-02-12	1,275,000	$8.00	5,983,549	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series E Preferred Stock	Disposition	2014-02-12	4,708,549	$0.00	4,708,549	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Each share of Series E Preferred Stock converted into 0.1667 shares of common stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The Series E Preferred Stock has no expiration date.
Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company "Pharmsandard". As the parent entity, Public Joint Stock Company "Pharmstandard" has voting and investment power over the shares of the Issuer held by Pharmstandard International S.A.